SOLARA
PharmaceuticalsSOLARA ACTIVE PHARMA SCIENCES LIMITED
NSE: SOLARABSE: 541540ISIN: INE624Z01016
₹581.05
-4.40 · -0.75%
As of 15 Jul 2024
Open
₹575.65
High
₹592.60
Low
₹561.70
Prev Close
₹585.45
52W High
₹639.70
52W Low
₹286.00
Volume
1.49 L
Mkt Cap
₹3,413 Cr
Fundamentals
Valuation & profitability
Market Cap
₹3,413 Cr
P/E Ratio
—
EPS (TTM)
₹-6.17
Book Value
—
Dividend Yield
—
ROCE
—
ROE
—
Sales Growth
—
Face Value
—
Key highlights
Auto-generated from live data
- SOLARA is trading above 3 of 5 of its key moving averages (10/20/50/100/200-DMA) — a bullish technical setup.
- At ₹581.05 it sits about 83% of the way up its 52-week range (₹286.00–₹639.70).
- Market capitalisation stands at ₹3,413 Cr.
Price chart
Daily candles + volume · SMA 20 / 50 / 200 · stored OHLC
Shareholding pattern
Shareholding data syncs daily.
Moving averages
Simple moving averages vs current price
SMA 10-Day
₹673.12Below
SMA 20-Day
₹635.34Below
SMA 50-Day
₹575.10Above
SMA 100-Day
₹560.33Above
SMA 200-Day
₹535.06Above
Price ranges
Where the price sits in each window
10-Day range₹581.05
₹615.35₹759.55
20-Day range₹581.05
₹501.95₹759.55
50-Day range₹581.05
₹471.55₹759.55
200-Day range₹581.05
₹422.00₹759.55
YTD range₹581.05
₹422.00₹759.55
52-Week range₹581.05
₹422.00₹759.55
Technical signals
Unfilled gaps acting as support / resistance
Unfilled Gap Down On 10 Feb, 2022 : 775.30 ~ 951.00RESISTANCE
Unfilled Gap Up On 13 Dec, 2018 : 270.00 ~ 269.95SUPPORT
Unfilled Gap Up On 14 Aug, 2018 : 259.35 ~ 247.00SUPPORT
Unfilled Gap Up On 13 Aug, 2018 : 239.00 ~ 235.25SUPPORT
Unfilled Gap Up On 10 Aug, 2018 : 226.95 ~ 224.05SUPPORT
Unfilled Gap Up On 06 Aug, 2018 : 216.25 ~ 209.80SUPPORT
Annual financials
Revenue, profit & EPS by financial year
| Year | Revenue | Net Profit | EPS | NPM |
|---|---|---|---|---|
| Mar 2023 | ₹1,444 Cr | ₹-22.00 Cr | ₹-6.17 | -1.52% |
| Mar 2022 | ₹1,268 Cr | ₹-59.00 Cr | ₹-16.27 | -4.65% |
| Mar 2021 | ₹1,617 Cr | ₹221 Cr | ₹61.62 | 13.67% |
| Mar 2020 | ₹1,322 Cr | ₹115 Cr | ₹42.68 | 8.7% |
| Mar 2020 | ₹1,322 Cr | ₹115 Cr | ₹42.68 | 8.7% |
| Mar 2019 | ₹1,387 Cr | ₹60 Cr | ₹23.10 | 4.33% |
| Mar 2019 | ₹1,387 Cr | ₹60 Cr | ₹23.10 | 4.33% |
| Mar 2018 | ₹521 Cr | ₹0.00 Cr | ₹0.00 | 0% |
Peer comparison
Other companies in Pharmaceuticals
| Company | P/E | Book Value | Sales Growth |
|---|---|---|---|
| SUNPHARMA SUN PHARMACEUTICAL INDUSTRIES LTD. | 39.1 | ₹98.33 | 10.1% |
| MARKSANS MARKSANS PHARMA LTD. | 23.8 | ₹11.85 | 5.8% |
| MOREPENLAB MOREPEN LABORATORIES LTD. | 20.81 | ₹6.43 | 16.6% |
| NEULANDLAB NEULAND LABORATORIES LTD. | 23.48 | ₹542.16 | 9.35% |
| GUFICBIO Gufic BioSciences Ltd. | 24.16 | ₹10.85 | 20.41% |
| DIVISLAB DIVI'S LABORATORIES LTD. | 41.01 | ₹266.77 | 9.47% |
| DRREDDY DR.REDDY'S LABORATORIES LTD. | 19.73 | ₹852.69 | 1.07% |
| RPGLIFE RPG LIFE SCIENCES LTD. | 17.14 | ₹105.02 | 5.73% |
| GLAND Gland Pharma Ltd | 53.6 | ₹242.00 | — |
| ZYDUSLIFE Zydus Lifesciences Ltd | 8.23 | ₹166.00 | 5% |
| SMSPHARMA SMS PHARMACEUTICALS LTD. | 9.58 | ₹42.07 | -8.73% |
| CIPLA CIPLA LTD. | 15.36 | ₹209.71 | 0.7% |
Dividend history
Per share, by ex-date
Ex-Date: 18 Aug 2021₹3.00
Ex-Date: 19 Nov 2020₹4.00
Ex-Date: 28 Jul 2020₹2.00
Ex-Date: 06 Aug 2019₹5.00
Bulk & block deals
Recent large transactions
| Date | Client | Type | Qty | Price |
|---|---|---|---|---|
| 11 Feb 2022 | REDDYVANGA VENTURES LLP | PURCHASE | 2,67,022 | ₹674.05 |
| 11 Feb 2022 | UNNATI MANAGEMENT CONSULTANTS LLP | SALE | 2,67,022 | ₹674.05 |
| 20 Dec 2021 | IMCO EMERGING MARKETS PUBLIC EQUITY LP | PURCHASE | 1,83,474 | ₹1,077.95 |
| 20 Dec 2021 | ONTARIO PENSION BOARD | SALE | 1,83,474 | ₹1,077.95 |
| 20 Dec 2021 | IMCO EMERGING MARKETS PUBLIC EQUITY LP | PURCHASE | 1,83,474 | ₹1,077.95 |
| 20 Dec 2021 | ONTARIO PENSION BOARD | SALE | 1,83,474 | ₹1,077.95 |
| 24 Nov 2021 | REDDYVANGA VENTURES LLP | SALE | 2,14,537 | ₹1,056.22 |
| 24 Nov 2021 | UNNATI MANAGEMENT CONSULTANTS LLP | PURCHASE | 2,14,537 | ₹1,056.23 |
| 10 May 2021 | ADITYA BIRLA SUN LIFE FLEXI CAP FUND | PURCHASE | 3,90,000 | ₹1,552.05 |
| 10 May 2021 | ADITYA BIRLA SUN LIFE MUTUAL FUND | PURCHASE | 1,94,000 | ₹1,552.05 |
| 10 May 2021 | CLASSIC OPPORTUNITIES FUND ULIF 033 16 12 09 CLAOPPFND 107 | PURCHASE | 2,57,823 | ₹1,552.05 |
| 10 May 2021 | PRONOMZ VENTURES LLP | SALE | 1,99,588 | ₹1,552.05 |
Fundamentals, financials & technicals sourced from niftytrader.in, cached and refreshed periodically.